TC BioPharm To Change Its Ratio Of ADSs To Ordinary Shares From 1 ADS Representing 1 Ordinary Share To 1 ADS Representing 20 Ordinary Shares, With December 15, 2023, Effective Date
Portfolio Pulse from Benzinga Newsdesk
TC BioPharm announced a change in the ratio of its ADSs to ordinary shares. Effective December 15, 2023, each ADS will represent 20 ordinary shares, a change from the current 1:1 ratio.
December 13, 2023 | 11:34 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
TC BioPharm's change in ADS ratio could lead to a temporary decrease in liquidity and potential confusion among investors as each ADS will now represent 20 ordinary shares.
Changes in ADS ratios can affect the stock's liquidity and market perception. The increase in the number of ordinary shares represented by each ADS could lead to a decrease in the trading volume of ADSs, as the price per ADS will likely increase to reflect the new ratio. This might confuse investors or be viewed negatively if not well communicated, potentially leading to a short-term drop in the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100